Stockscreener 앱 받기
13.50
6.32%
-0.91
시간 외 거래:
13.64
0.14
+1.04%
Polyrizon Ltd 주식(PLRZ)의 최신 뉴스
Market Trends: Will Polyrizon Ltd stock hit new highs in YEAR2026 Buyback Activity & Stepwise Trade Execution Plans - baoquankhu1.vn
Polyrizon (PLRZ) CTO details initial share and option holdings - Stock Titan
[Form 3] Polyrizon Ltd. Initial Statement of Beneficial Ownership - Stock Titan
Polyrizon (PLRZ) Chief Science Officer reports share and option holdings - Stock Titan
Director Itzhaik Asaf details restricted share holdings at Polyrizon (PLRZ) - Stock Titan
Polyrizon (PLRZ) director discloses initial restricted share holdings - Stock Titan
Polyrizon (PLRZ) director discloses vested and restricted share holdings - Stock Titan
Carmel Liron details Polyrizon (PLRZ) restricted share ownership and vesting - Stock Titan
Polyrizon (PLRZ) CEO Tomer Izraeli details initial share and option holdings - Stock Titan
Polyrizon (PLRZ) CFO details initial share and option holdings - Stock Titan
Oz Adler Net Worth (2026) - GuruFocus
Polyrizon signs CRO agreement for biocompatibility studies - Investing.com South Africa
Polyrizon Taps Global CRO to Run Key Preclinical Safety Studies Ahead of First Clinical Trials - TipRanks
Polyrizon Signs an Agreement with Leading Global Preclinical CRO as Part of Clinical Development Program - The Manila Times
Polyrizon (PLRZ) signs global CRO pact to advance nasal hydrogel trials - Stock Titan
Nasal allergy startup Polyrizon readies human trials with safety tests - Stock Titan
Eli Zamir reports ≤5% stake in Polyrizon Ltd. (PLRZ) via Schedule 13G - Stock Titan
Polyrizon (PLRZ) Institutional Ownership 2026 - MarketBeat
Polyrizon Announces GMP Manufacturing of Clinical Trial Material with Eurofins CDMO AmatsiAquitaine S.A.S for Planned U.S. Clinical Study - marketscreener.com
Polyrizon completes GMP batch for intranasal product trial By Investing.com - Investing.com South Africa
Aug Intraday: Does Polyrizon Ltd have strong fundamentalsRate Hike & AI Optimized Trade Strategies - baoquankhu1.vn
Polyrizon Announces GMP Manufacturing of Clinical Trial Material (CTM) with Eurofins CDMO AmatsiAquitaine S.A.S for Planned U.S. Clinical Study - Bitget
Polyrizon completes GMP batch for intranasal product trial - Investing.com India
Polyrizon Completes GMP Clinical Material for Planned U.S. Intranasal Study - TipRanks
Polyrizon (Nasdaq: PLRZ) makes GMP CTM for planned U.S. study - Stock Titan
Polyrizon makes GMP batch for planned U.S. nasal allergy, virus trial - Stock Titan
PLRZ Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Polyrizon (PLRZ) Amendment: L.I.A. Pure Capital Lists ≤5% Ownership - Stock Titan
What catalysts could drive Polyrizon Ltd. stock higher2026 Price Swings & Daily Price Action Insights - Naître et grandir
Polyrizon retains Nasdaq listing following hearings panel - MSN
PLRZ Technical Analysis & Stock Price Forecast - Intellectia AI
Polyrizon Ltd. (PLRZ) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
PLRZ Should I Buy - Intellectia AI
Polyrizon reports nasal deposition study results for naloxone By Investing.com - Investing.com Australia
Polyrizon reports nasal deposition study results for naloxone - Investing.com
Polyrizon Reports Superior Nasal Deposition for Naloxone Formulation in Comparative Study - TipRanks
Polyrizon (Nasdaq: PLRZ) reports enhanced naloxone nasal deposition study - Stock Titan
Polyrizon Announces Successful Study of its Naloxone Formulation Demonstrating Enhanced Nasal Deposition Profile Versus Commercial Reference Product - marketscreener.com
Lab test: Polyrizon nasal naloxone hits target area 94.6% vs 79.6% - Stock Titan
S&P 500 Gains 1%; April Jobs Top Expectations - Intellectia AI
Moonage Media Spotlights Polyrizon (Nasdaq: PLRZ): Unveils NASARIX™, Drug-Free Allergy Blocker - Yahoo Finance
Polyrizon Ltd. announces $4.97 million securities offering - MSN
Polyrizon recives Nasdaq delisting notice - MSN
Is Polyrizon Ltd. stock a value trapJuly 2025 Retail & Weekly High Return Forecasts - mfd.ru
Polyrizon signs MOU to acquire 51% stake in Arrow Aviation By Investing.com - Investing.com South Africa
Polyrizon stock rises on potential acquisition of Arrow Aviation - Investing.com
Will Polyrizon Ltd. stock hit new highs in YEARQuarterly Trade Report & Smart Money Movement Tracker - mfd.ru
How Polyrizon Ltd. stock benefits from tech adoptionWeekly Stock Report & Weekly High Return Opportunities - mfd.ru
Polyrizon stock rises on potential acquisition of Arrow Aviation By Investing.com - Investing.com Canada
Polyrizon intends to secure controlling stake in profitable private jet operator - marketscreener.com
Polyrizon signs MOU to acquire 51% stake in Arrow Aviation - Investing.com
Polyrizon Intends to Secure Controlling Stake in Profitable Private Jet Operator - The Manila Times
Biotech Polyrizon lines up $5.8M deal for $19M private jet firm - Stock Titan
Polyrizon to develop intranasal formulation of Clearmind’s MEAI drug By Investing.com - Investing.com Nigeria
Clearmind partners with Polyrizon to develop intranasal MEAI formulation By Investing.com - Investing.com Nigeria
1.20%
0.06%
자본화:
|
볼륨(24시간):